Q4 2024 Earnings Call Transcript March 11, 2025 Voyager Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...

LEXINGTON, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company ...

Voyager program scientist at NASA Headquarters in Washington, in a statement. “Every bit of additional data we have gathered since then is not only valuable bonus science for heliophysics ...

The same capsid in the VY1706 (tau silencing) gene therapy program achieved desired activity levels and was well-tolerated in three-month NHP studies. Voyager no longer anticipates filing an ...

IND filings expected in 2025 for GBA1 and FA programs - LEXINGTON, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to ...

The farthest spacecraft from Earth are shutting off instruments in interstellar space, but their mission in interstellar space isn’t over yet ...

Voyager program scientist at NASA Headquarters in Washington. "Every bit of additional data we have gathered since then is not only valuable bonus science for heliophysics, but also a testament to ...

NASA is turning off more science instruments on its Voyager 1 and Voyager 2 probes that could help extend the life of the ...